Abstract
Background & Objective: A series of novel 3-Substituted-1,3,4,5-Tetrahydro-2H-benzo [b] azepine-2-one Derivatives (4, 5, 7, 10, 12, 5a-j, 8a-e) were synthesized from 1,2,3,4-Tetrahydro-1- naphthalenone. The structures of these compounds were confirmed by IR, 1H NMR, 13C NMR, MASS spectra and elemental analysis. Their anticonvulsant activity was evaluated by the maximal electroshock (MES) test, subcutaneous pentylenetetrazol (scPTZ) test, and their neurotoxicity was evaluated by the rotarod neurotoxicity test. Compound 4 showed the maximum anticonvulsant activity against the maximal electroshock test (ED50=26.4, PI =3.2) and against the subcutaneous pentylenetetrazol test (ED50=40.2, PI =2.1).
Conclusion: Possible structure-activity relationship was discussed.
Keywords: Anticonvulsant activity, toxicity, benzotriazoloazepine, synthesis, pharmacological, maximal electroshock test.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Synthesis and Anticonvulsant Activity of 3-(alkylamino, alkoxy)-1,3,4,5- Tetrahydro-2H-benzo [b] azepine-2-one Derivatives
Volume: 17 Issue: 6
Author(s): Xia Huang, Tie Chen, Rong-Bi Han and Feng-Yu Piao*
Affiliation:
- Department of Chemistry, College of Science, Yanbian University, Yanji 133002, Jilin Province,China
Keywords: Anticonvulsant activity, toxicity, benzotriazoloazepine, synthesis, pharmacological, maximal electroshock test.
Abstract: Background & Objective: A series of novel 3-Substituted-1,3,4,5-Tetrahydro-2H-benzo [b] azepine-2-one Derivatives (4, 5, 7, 10, 12, 5a-j, 8a-e) were synthesized from 1,2,3,4-Tetrahydro-1- naphthalenone. The structures of these compounds were confirmed by IR, 1H NMR, 13C NMR, MASS spectra and elemental analysis. Their anticonvulsant activity was evaluated by the maximal electroshock (MES) test, subcutaneous pentylenetetrazol (scPTZ) test, and their neurotoxicity was evaluated by the rotarod neurotoxicity test. Compound 4 showed the maximum anticonvulsant activity against the maximal electroshock test (ED50=26.4, PI =3.2) and against the subcutaneous pentylenetetrazol test (ED50=40.2, PI =2.1).
Conclusion: Possible structure-activity relationship was discussed.
Export Options
About this article
Cite this article as:
Huang Xia , Chen Tie , Han Rong-Bi and Piao Feng-Yu *, Synthesis and Anticonvulsant Activity of 3-(alkylamino, alkoxy)-1,3,4,5- Tetrahydro-2H-benzo [b] azepine-2-one Derivatives, CNS & Neurological Disorders - Drug Targets 2018; 17 (6) . https://dx.doi.org/10.2174/1871527317666180704101332
DOI https://dx.doi.org/10.2174/1871527317666180704101332 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Risk Factors of Alzheimers Disease Among Iranian Population
Current Alzheimer Research Disease Outcome, Alexithymia and Depression are Differently Associated with Serum IL-18 Levels in Acute Stroke
Current Neurovascular Research Apathy Is not Associated with Performance in Brief Executive Tests in Patients with Mild Cognitive Impairment and Mild Alzheimers Disease
Current Alzheimer Research Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex
Current Drug Metabolism Cannabinoid Modulation of Fear Extinction Brain Circuits: A Novel Target to Advance Anxiety Treatment
Current Pharmaceutical Design The Therapeutic Target Hsp90 and Cancer Hallmarks
Current Pharmaceutical Design Quality of Life in People with Coeliac Disease: Psychological and Socio- Economic Aspects
Endocrine, Metabolic & Immune Disorders - Drug Targets Structural Basis of Agonist Selectivity for Different nAChR Subtypes: Insights from Crystal Structures, Mutation Experiments and Molecular Simulations
Current Pharmaceutical Design Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Quantum Chemical Approaches: Semiempirical Molecular Orbital and Hybrid Quantum Mechanical/Molecular Mechanical Techniques
Current Pharmaceutical Design Recent Progress on the Studies of the True Catalyst in the Heck Reaction with Supported Pd Particles
Current Organic Synthesis Tachykinins and Neuropsychiatric Disorders
Current Drug Targets Microwave Accelerated Labeling Methods in the Synthesis of Radioligands for Positron Emission Tomography Imaging
Current Radiopharmaceuticals Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones
Central Nervous System Agents in Medicinal Chemistry Feature Based Fusion of Multimodal Medical Image Slices with Combined Transforms
Current Medical Imaging B Cell Modulation Strategies in Autoimmunity: The SLE Example
Current Pharmaceutical Design Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimers Disease
Current Topics in Medicinal Chemistry All Cognitive Systems but Speed and Visuospatial Functions Reduce the Effect of CSF Pathology on Other Systems
Current Alzheimer Research Membrane Estrogen Receptors Acting in the Central Nervous System
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Hypocretins and their Role in Narcolepsy
CNS & Neurological Disorders - Drug Targets